Evidence map›Paper›PMID 33042110›Full record

ArticleFrontiers in immunology2020

G-CSF and G-CSFR Modulate CD4 and CD8 T Cell Responses to Promote Colon Tumor Growth and Are Potential Therapeutic Targets.

Ioannis Karagiannidis, Stephanie J Jerman, Damian Jacenik, Brandon B Phinney, Ruoxin Yao, Eric R Prossnitz, Ellen J Beswick

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. MAIT Cells Modulate Innate Immune Cells and Inhibit Colon Cancer Growth.bioRxiv : the preprint server for biology · 2024
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Ioannis KaragiannidisDivision of Gastroenterology, Department of Internal Medicine, University of Utah, Salt Lake City, UT, United States.
Stephanie J JermanDepartment of Molecular Genetics and Microbiology, University of New Mexico Health Sciences Center Albuquerque, Albuquerque, NM, United States.
Damian JacenikDivision of Molecular Medicine, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, United States.
Brandon B PhinneyDepartment of Molecular Genetics and Microbiology, University of New Mexico Health Sciences Center Albuquerque, Albuquerque, NM, United States.
Ruoxin YaoDivision of Gastroenterology, Department of Internal Medicine, University of Utah, Salt Lake City, UT, United States.
Eric R ProssnitzDivision of Molecular Medicine, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, United States.
Ellen J BeswickDivision of Gastroenterology, Department of Internal Medicine, University of Utah, Salt Lake City, UT, United States.
University of New Mexico · USUniversity of Utah · US

Funding

UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI KATHARINE S ULLMAN · 1986 to 2026
$72.6M
WOMEN'S CANCERS RESEARCH PROGRAMP30CA118100 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Yolanda Sanchez · 2005 to 2026
$57.1M
Unfolded Protein Response and Autophagy in T Helper Cell Effector FunctionP20GM121176 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Monica Rosas Lemus · 2017 to 2026
$24.9M
FAIR Data Competency and Machine Learning Readiness for Biomedical ScientistsK12GM088021 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI REBECCA S. HARTLEY, Diane Lidke · 2009 to 2026
$16.4M
Molecular Mechanisms and Applications of Novel ER/GPER-selective LigandsR01CA194496 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI ARTERBURN, JEFFREY B, PROSSNITZ, ERIC R · 2016 to 2025
$4.1M
G protein-coupled estrogen receptor GPER and breast carcinogenesisR01CA163890 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI PROSSNITZ, ERIC R · 2012 to 2023
$3.3M
G-CSF inhibition as a colorectal cancer therapyR01CA207051 · NCI · UNIVERSITY OF UTAH · PI BESWICK, ELLEN J. · 2016 to 2021
$1.7M
NCI NIH HHS P30 CA042014NCI NIH HHS P30 CA118100NCI NIH HHS R01 CA163890NCI NIH HHS R01 CA194496NCI NIH HHS R01 CA207051NIGMS NIH HHS K12 GM088021NIGMS NIH HHS P20 GM121176
6 · The paper itself

Abstract

Cytokines are known to shape the tumor microenvironment and although progress has been made in understanding their role in carcinogenesis, much remains to learn regarding their role in tumor growth and progression. We have identified granulocyte colony-stimulating factor (G-CSF) as one such cytokine, showing that G-CSF is linked with metastasis in human gastrointestinal tumors and neutralizing G-CSF in a mouse model of colitis-associated cancer is protective. Here, we set out to identify the role of G-CSF and its receptor, G-CSFR, in CD4

Indexed as

Cytotoxicity, ImmunologicAnimalsCD8-Positive T-LymphocytesCell Line, TumorCoculture TechniquesColonic NeoplasmsDNA-Binding ProteinsFemaleGranulocyte Colony-Stimulating FactorInterferon-gammaInterleukin-10Interleukin-17Lymphocytes, Tumor-InfiltratingMaleMice, Inbred C57BLMice, KnockoutCsf3r protein, mouseDNA-Binding ProteinsGranulocyte Colony-Stimulating FactorIFNG protein, mouseIL10 protein, mouseIl17a protein, mouseInterferon-gammaInterleukin-10Interleukin-17Rag2 protein, mouseReceptors, Colony-Stimulating Factorcolorectal cancercytokinesG-CSFG-CSF receptorT cellstumor microenvironment

Identifiers

PMID33042110
PMCPMC7522314
OpenAlexW3092594203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.